Condition Vasoregulation Function Endothelium in Patients With CML Getting TKI II Generation Bosutinib

Clinical trial NCT05682924 · RECRUITING

Trial details

NCT number: NCT05682924
Sponsor: Samara State Medical University
Status: RECRUITING
Study type: OBSERVATIONAL

Chronic Myeloid Leukaemia

Start date: 2022-10-01
Primary completion: 2025-09-01
Enrollment: 105

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.